Gustavo Denegri & family (#1977)
- $ 2 B
- Biotech
- Italy
- M
- 89 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Gustavo Denegri is the chairman of biotech company DiaSorin SpA; the bulk of his fortune is a 45% stake in the publicly-traded company. In 2000, his private equity firm acquired the distressed DiaSorin from American Standard Companies and built it into a global player in diagnostics. His first breakthrough came when his Gruppo Pro-Ind, a components firm, merged with Piaggio, owner of motor scooters Vespa and Aprilia. He is one of few Italian businessmen to have built billion-dollar companies in more than one sector. His firm Investimenti is run by his son Michele and has a diverse portfolio, including medical technology, real estate and TV production.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Gustavo Denegri & family’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Gustavo Denegri & family’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $2.1B
(May 4, 2026)
© Iconic Billionaires